Extracorporeal Membrane Oxygenation Market Size | Report 2028

Extracorporeal Membrane Oxygenation Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Modality (Venoarterial extracorporeal membrane oxygenation, Venovenous extracorporeal membrane oxygenation, and Arteriovenous extracorporeal membrane oxygenation), Application (Respiratory and Cardiology), and Age Group (Adults, Pediatrics, and Neonates)

Publication Month : Nov 2022

  • Report Code : TIPHE100001219
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 162
Inquire Before Buy

PRICING

$4550

$3640

The global extracorporeal membrane oxygenation market was valued at US$ 546.73 million in 2021 and is projected to reach US$ 677.64 million by 2028. The market is estimated to grow at a CAGR of 3.1% during 2022–2028.

Extracorporeal membrane oxygenation (extracorporeal membrane oxygenation) is a treatment used for blood circulation through an artificial lung. The system helps provide heart-lung bypass route outside the body. This also provides support to patients who need a lung transplant. The extracorporeal membrane oxygenation market growth is attributed to the rising prevalence of cardiovascular diseases and respiratory failures and the growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures. However, complications associated with extracorporeal membrane oxygenation hinder the growth of the market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Extracorporeal Membrane Oxygenation Market: Strategic Insights

extracorporeal-membrane-oxygenation-market
Market Size Value inUS$ 546.73 Million in 2021
Market Size Value byUS$ 677.64 Million by 2028
Growth rateCAGR of 3.1% from 2022 to 2028
Forecast Period2022-2028
Base Year2021
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Lucrative Regions in Extracorporeal Membrane Oxygenation Market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights

Growing Adoption of extracorporeal membrane oxygenation in Lung Transplantation Procedures Drive extracorporeal membrane oxygenation Market Growth

Lung transplantation is a life-saving treatment option for patients suffering from end-stage lung diseases, such as COPD, Idiopathic pulmonary fibrosis (IPF), and cystic fibrosis, to improve the quality of life. extracorporeal membrane oxygenation is a versatile tool used in all lung transplantation phases, such as preoperative, intraoperative, and postoperative periods. It acts as a bridge for patient undergoing lung transplantation. Therefore, the adoption of extracorporeal membrane oxygenation during lung transplantation is growing rapidly to manage patients with life-threatening lung disease. According to the Scientific Registry of Transplant Recipients (SRTR), ~4,600 lung transplants are performed across the world every year, of which 55% were performed in North America. According to the same source, ~2,759 patients underwent lung transplantation, and ~3,243 patients were added to the lung transplant waiting list in the US. Primary graft dysfunction (PGD) is the leading cause of death after a lung transplant. Thus, extracorporeal membrane oxygenation is used penultimately in treating PGD post lung transplantation. According to National Library Medicine (NLM), in 2022, the overall incidence of PGD is 30%, in which the risk factors include preoperative donor lung ischemia, organ acquisition, preservation techniques, and intraoperative organ implantation and reperfusion. Thus, the demand for extracorporeal membrane oxygenation equipment is growing for treating patients suffering from PGD.

Modality-Based Insights

The global extracorporeal membrane oxygenation market, based on modality, is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. The venoarterial extracorporeal membrane oxygenation segment held the largest share of the market in 2021. Moreover, the same segment is anticipated to register a highest CAGR of 3.8% in the market during the forecast period. Venoarterial (VA) extracorporeal membrane oxygenation supports the patient's heart and lungs by pushing the blood through the circuit without getting through the patient's heart. This type of extracorporeal membrane oxygenation takes blood out of a large vein and back it into a large artery, allowing oxygen-rich blood to circulate through the body even if the heart is too weak to pump. Veno-arterial extracorporeal membrane oxygenation (VA-extracorporeal membrane oxygenation) has been widely applied over the last decade. It is an effective and valuable therapeutic option in refractory cardiogenic shock of various etiologies. It showed promising results in the specific setting of in-hospital cardiac arrest, and survival rates with good neurological outcomes are reported between 20% and 40%.

Extracorporeal Membrane Oxygenation Market, by Modality – 2021 and 2028

Extracorporeal Membrane Oxygenation Market, by Modality – 2021 and 2028

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Age Group-Based Insights

Based on age group, the global extracorporeal membrane oxygenation market is segmented into adults, pediatrics and neonates. The adults segment held the largest share of the market in 2021 and is expected to register a CAGR of 3.7% during 2022–2028. The extracorporeal membrane oxygenation help the adult patients suffering from cardiac or respiratory failure. Moreover, the recent technological advancements in extracorporeal membrane oxygenation circuits have led to reduction in the rate of technical issues and complication.

Extracorporeal Membrane Oxygenation – Market Segmentation

The extracorporeal membrane oxygenation market is segmented on the basis of modality, application, age group, and geography. Based on modality, the market is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, arteriovenous extracorporeal membrane oxygenation. Based on application, the extracorporeal membrane oxygenation market is bifurcated into respiratory and cardiology. In terms of end user, the extracorporeal membrane oxygenation market is segmented into adults, pediatrics, and neonates. By geography, the extracorporeal membrane oxygenation market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). 

Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios to dominate the extracorporeal membrane oxygenation market share. Moreover, the market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world. The market is anticipated to flourish in the coming years owing to the development of new innovative products by market players.

Company Profiles

  • Terumo Group
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • LivaNova Plc
  • Nipro Medical Corporation
  • Eurosets S.R.L.
  • Getinge AB
  • Braile Biomedica
  • Fresenius Medical Care AG & Co KGaA
  • ABIOMED Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Modality, Application, and Age Group

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


Which segment is dominating the extracorporeal membrane oxygenation market?

The global extracorporeal membrane oxygenation market based on modality is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. In 2021, the venoarterial extracorporeal membrane oxygenation segment accounted for the highest share, moreover the same segment is expected to grow faster at a CAGR of 3.8% in the forecast period.

Who are the major players in market the extracorporeal membrane oxygenation market?

The extracorporeal membrane oxygenation market majorly consists of the players such as Terumo Group, Medtronic Plc. MicroPort Scientific Corporation, LivaNova Plc, Nipro Medical Corporation, Eurosets S.R.L., Getinge AB, Braile Biomedica, Fresenius Medical Care AG & Co KGaA, and ABIOMED Inc.

What are the restraining factors for the extracorporeal membrane oxygenation market across the country?

The complications associated with extracorporeal membrane oxygenation is expected to restrict the market growth during the forecast period

What are the driving factors for the extracorporeal membrane oxygenation market across the country?

Factors such as the rising prevalence of cardiovascular diseases and respiratory failures and further growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures.

What is the extracorporeal membrane oxygenation market?

Extracorporeal membrane oxygenation (ECMO) is a treatment used for the circulation of blood through an artificial lung back into the bloodstream. The system enables to provide heart-lung bypass route outside the body. This also provides support to patients who need a lung transplant. The main purpose of extracorporeal membrane oxygenation is to provide oxygen to the body to heal or rest.

Which region is dominating the extracorporeal membrane oxygenation market?

The global extracorporeal membrane oxygenation market on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and the South & Central America. In 2021, North American region held largest market share. However, Asia Pacific region is estimated to grow at the fastest CAGR of 3.9% during the forecast period.

The List of Companies - Extracorporeal Membrane Oxygenation Market

  1. Terumo Group
  2. Medtronic Plc
  3. MicroPort Scientific Corporation
  4. LivaNova Plc
  5. Nipro Medical Corporation
  6. Eurosets S.R.L.
  7. Getinge AB
  8. Braile Biomedica
  9. Fresenius Medical Care AG & Co KGaA
  10. ABIOMED Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Extracorporeal Membrane Oxygenation Market